ArticleInternational journal of molecular sciences2025

Novel Compounds Target Aberrant Calcium Signaling in the Treatment of Relapsed High-Risk Neuroblastoma.

Dana-Lynn T Koomoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.